PressOctober 5, 2023 FSD Pharma Wins $2.8 Million Dollar Award Plus Accruing Interest from Dr. Raza Bokhari; Set Aside Motion Brought by Bokhari, Now CEO of Medicus Pharma, Dismissed by the Ontario Superior Court of Justice
PressOctober 4, 2023 Safe Supply Streaming Co. Ltd. to Begin Trading on the CSE Today, October 3, 2023
PressOctober 4, 2023 PSYC’s Psychedelic Spotlight to be Media Partner for 2023 reMind Psychedelic Business Forum
PressOctober 4, 2023 Enveric Biosciences Announces its Psybrary™ Portfolio Now Totals Over 1000 Psychedelic-Inspired Drug Candidates
PressOctober 3, 2023 Atai Life Sciences Announces Completion of Phase 1 Study of VLS-01 in Healthy Participants
PressOctober 3, 2023 Cybin Completes Dosing in Phase 2 Study of CYB003 for the Treatment of Major Depressive Disorder
PressOctober 3, 2023 The Future of Psychedelic Access in Canada: PsyCan Releases White Paper Reviewing Regulatory Options for Psychedelics
PressOctober 3, 2023 Numinus Announces Psychedelic Program for Mental Distress Associated with Chronic and Serious Illness through Cedar Clinical Research
PressOctober 2, 2023 Atai Life Sciences Announces Completion of Phase 1 Study of VLS-01 in Healthy Participants
PressOctober 2, 2023 GH Research Provides Updates and Guidance on its Clinical Development Program for GH001 in Treatment-Resistant Depression
PressSeptember 29, 2023 Filament Health Corp. Announces Non-Brokered Private Placement Unit Offering Led By Negev Capital
PressSeptember 28, 2023 atai Life Sciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
BlogSeptember 28, 2023 Psyched Wellness Is Pleased To Announce Sponsorship and Activation at The Wonderland Conference in Miami on Nov 9 – 11
PressSeptember 28, 2023 Mydecine Innovations Group Announces Expected U.K. Dual Listing Admission Date
PressSeptember 27, 2023 Canadian Veteran Receives Approval for APEX’s Psilocybin Therapy Through Health Canada’s Special Access Program
PressSeptember 27, 2023 PharmaTher Announces FDA Acceptance, As a Priority Original Abbreviated New Drug Application, for KETARX™ (Ketamine)
